This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horne, D
Right arrow Articles by Tomasz, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horne, D
Right arrow Articles by Tomasz, A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1981 May; 19(5): 745-753

Hypersusceptibility of penicillin-treated group B streptococci to bactericidal activity of human polymorphonuclear leukocytes.

D Horne and A Tomasz

ABSTRACT

Pretreatment of serotype Ib group B streptococci with benzylpenicillin, other beta-lactam antibiotics, or vancomycin increased the susceptibility of these bacteria to the bactericidal activity of a mixture of human polymorphonuclear leukocytes and normal human serum. Increased susceptibility of the bacteria to killing by phagocytes was elicited even by exposure to subinhibitory levels of the beta-lactam antibiotics. Inhibitors of protein synthesis did not induce such susceptibility. We investigated the possible biochemical basis of penicillin-induced susceptibility to phagocytosis. Penicillin treatment induced the release of substantial quantities of group B streptococcal surface components into the growth medium (lipoteichoic acid, lipid, and capsular polysaccharide). Labeling of the live streptococci with 3H-labeled penicillin was used to evaluate the effect of exposure to subinhibitory concentrations of this antibiotic on the penicillin-binding proteins. Our results suggested that beta-lactam antibiotics and components of the immune system may act in concert to eliminate invading bacteria.


Antimicrob Agents Chemother. 1981 May; 19(5): 745-753




This article has been cited by other articles:

  • Moore, L. J., Pridmore, A. C., Dower, S. K., Read, R. C. (2004). The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae. J Antimicrob Chemother 54: 76-78 [Abstract] [Full Text]  
  • TOMASZ, A. (1982). Penicillin-Binding Proteins in Bacteria. ANN INTERN MED 96: 502-504 [Abstract]  
  • Rein, M. F. (1981). Treatment of Neurosyphilis. JAMA 246: 2613-2614 [Abstract]